Fund Holdings — FCPM III SERVICES B.V.

Total Portfolio Value
$750.41M
Total Bought
$28.78M
Total Sold
$7.99M
Net Transaction
+$20.80M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MAPLIGHT THERAPEUTICS INC(MPLT)3,226,4003,226,400065,593115,63415.41%+50,041
AURA BIOSCIENCES INC(AURA)04,053,775+4,053,775028,7823.84%+28,782
REPLIMUNE GROUP INC(REPL)2,808,3682,808,368021,48431,0894.14%+9,605
VOR BIOPHARMA INC(VOR)4,117,3544,117,354073,45475,80010.10%+2,347
DYNE THERAPEUTICS INC(DYN)4,644,3863,848,256-796,13084,20385,47011.39%+1,267
DAMORA THERAPEUTICS INC(DMRA)2,441,0002,441,000063,22263,4908.46%+269
CRESCENT BIOPHARMA INC.(CBIO)1,677,8521,677,852030,82230,2014.02%-621
BICYCLE THERAPEUTICS PLC3,468,4303,468,430016,09414,7061.96%-1,387
ENGENE HOLDINGS INC
*W EXP 10/31/202
2,878,1482,878,14807,2828340.11%-6,447
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
9,198,9008,490,353-708,547294,457287,73838.34%-6,719
ENGENE HOLDINGS INC
COM
9,632,5619,632,561065,59816,6642.22%-48,933
Page 1 of 1
FCPM III SERVICES B.V. — 13F Holdings — Q2 2026 | TickerTrail